Daniel Offen

Daniel Offen

Tel Aviv University

H-index: 73

Asia-Israel

About Daniel Offen

Daniel Offen, With an exceptional h-index of 73 and a recent h-index of 32 (since 2020), a distinguished researcher at Tel Aviv University, specializes in the field of Neuroscience.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model

Cannabidiol-containing compositions and uses thereof

Computationally engineered CRISPR-SpyCas9 high-fidelity variants with improved specificity and reduced non-specific DNA damage

CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology (vol 146, pg 209, 2023)

Vesicles comprising a pten inhibitor and uses of same

Mesenchymal stem cell-derived extracellular vesicles as proposed therapy in a rat model of cerebral small vessel disease

Peptides for the treatment of renal disorders

Exosomes from mesenchymal cells for the treatment of neurological diseases

Daniel Offen Information

University

Position

___

Citations(all)

17070

Citations(since 2020)

5204

Cited By

13767

hIndex(all)

73

hIndex(since 2020)

32

i10Index(all)

184

i10Index(since 2020)

117

Email

University Profile Page

Tel Aviv University

Google Scholar

View Google Scholar Profile

Daniel Offen Skills & Research Interests

Neuroscience

Top articles of Daniel Offen

Title

Journal

Author(s)

Publication Date

Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model

Neurotherapeutics

Talya Shacham

Daniel Offen

Gerardo Z Lederkremer

2024/2/16

Cannabidiol-containing compositions and uses thereof

2023/4/13

Computationally engineered CRISPR-SpyCas9 high-fidelity variants with improved specificity and reduced non-specific DNA damage

bioRxiv

Roy Rabinowitz

Oded Shor

Johanna Zerbib

Shay Herman

Natalie Zelikson

...

2023/4/11

CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology (vol 146, pg 209, 2023)

Brain

Shay Herman

Ruth Djaldetti

Brit Mollenhauer

Daniel Offen

2023/1/4

Vesicles comprising a pten inhibitor and uses of same

2023/10/19

Mesenchymal stem cell-derived extracellular vesicles as proposed therapy in a rat model of cerebral small vessel disease

Shivkanya Fuloria

Vetriselvan Subramaniyan

Rajiv Dahiya

Sunita Dahiya

Kalvatala Sudhakar

...

2021/2/25

Peptides for the treatment of renal disorders

2022/8/11

Exosomes from mesenchymal cells for the treatment of neurological diseases

2022/8/1

Novel nanoparticle improves intracellular uptake and cardioprotective efficacy of DJ-1 mimic peptide

Journal of Molecular and Cellular Cardiology

Shengjie Lu

Peng Liu

Sauri Hernandez Resendiz

Jasper Tee Loong Chua

Daniel Offen

...

2022/12/31

A novel rodent model of hypertensive cerebral small vessel disease with white matter hyperintensities and peripheral oxidative stress

International Journal of Molecular Sciences

Reut Guy

Rotem Volkman

Ella Wilczynski

Chana Yagil

Yoram Yagil

...

2022/5/25

Extracellular vesicles over adeno-associated viruses: Advantages and limitations as drug delivery platforms in precision medicine

Nataly Yom-Tov

Reut Guy

Daniel Offen

2022/11/1

Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants

Computational and Structural Biotechnology Journal

Oded Shor

Roy Rabinowitz

Daniel Offen

Felix Benninger

2022/1/1

Egzosomy pochodzące z komórek mezenchymalnych do leczenia zaburzeń neurologicznych

2022/9/26

Methods and compositions for modulating myeloperoxidase (mpo) expression

2021/7/15

Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases

Shay Herman

Idan Fishel

Daniel Offen

2021/12/1

Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease

Molecular psychiatry

Meygal Kahana

Abraham Weizman

Martin Gabay

Yelena Loboda

Hadar Segal-Gavish

...

2021/6

Mesenchymal stem cells for the treatment of CNS diseases

2021/11/30

Single-base resolution: increasing the specificity of the CRISPR-Cas system in gene editing

Roy Rabinowitz

Daniel Offen

2021/3/3

Mesenchymal cell-derived exosomes to treat neurological disorders

2021/11/25

Induced neural differentiation of human mesenchymal stem cells affects lipid metabolism pathways

bioRxiv

Pnina Green

Inna Kan

Ronit Mesilati-Stahy

Nurit Argov-Argaman

Daniel Offen

2021/1/18

See List of Professors in Daniel Offen University(Tel Aviv University)

Co-Authors

H-index: 106
Abraham Weizman

Abraham Weizman

Tel Aviv University

H-index: 62
Yoram Cohen

Yoram Cohen

Tel Aviv University

H-index: 50
Shulamit Levenberg

Shulamit Levenberg

Technion - Israel Institute of Technology

H-index: 42
Rachela Popovtzer

Rachela Popovtzer

Bar-Ilan University

H-index: 21
Oshra Betzer

Oshra Betzer

Bar-Ilan University

H-index: 15
Javier Ganz

Javier Ganz

Harvard University

academic-engine